Microglia are immune cells in the brain. When they become overactive, they can cause inflammation and damage to the brain, similar to autoimmune diseases.
See the scientific wording
Overactivation of microglia can lead to neuroinflammation and damage to brain tissue, similar to autoimmune diseases.
Correlational — new studies may shift this
Observational2 low-scoring studies link this claim to the outcome, but causation is not established.
What the research says
2 studies reviewedSupporting (2)
Cross-Sectional StudyIn vitro2024
The study shows that when brain immune cells called microglia are activated, they release chemicals that cause inflammation, which supports the idea that overactive microglia can harm the brain.
Cross-Sectional StudyIn vitro2026
The study shows that when brain immune cells get too activated, they release harmful substances that cause inflammation and damage nearby brain cells, and a substance that calms these immune cells can protect the brain.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When the brain's immune cells become too active, they activate a switch inside them that makes them release harmful chemicals. These chemicals travel to nearby brain cells and stop them from producing important growth factors, which causes the brain cells to get damaged and die.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Microglia are immune cells in the brain. When they become overactive, they can cause inflammation and damage to the brain, similar to autoimmune diseases.
Mechanism
2 studiesThe brain's immune cells, when overactive, use a special switch to make harmful chemicals. These chemicals hurt brain cells by taking away the nutrients they need to survive. Stopping that switch protects the brain cells.
When the brain's immune cells become too active, they activate a switch inside them that makes them release harmful chemicals. These chemicals travel to nearby brain cells and stop them from producing important growth factors, which causes the brain cells to get damaged and die.
Overactivation of microglia triggers the activation of the NF-κB signaling pathway, which moves into the nucleus.
The activated NF-κB promotes the production and release of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6, as well as oxidative stress molecules including reactive oxygen species and nitric oxide.
The released inflammatory and oxidative molecules act on nearby neurons, reducing the expression of brain-derived neurotrophic factor and nerve growth factor, which impairs neuronal function and leads to damage.
Evidence from Studies
Last searched 1mo ago
Supporting (2)
Community contributions welcome
TREM2 regulates BV2 microglia activation and influences corticosterone-induced neuroinflammation in depressive disorders.
The study shows that when brain immune cells called microglia are activated, they release chemicals that cause inflammation, which supports the idea that overactive microglia can harm the brain.
Avarol protects HT22 neuronal cells from BV2 microglia cell-derived neuroinflammation in lipopolysaccharide-induction model
The study shows that when brain immune cells get too activated, they release harmful substances that cause inflammation and damage nearby brain cells, and a substance that calms these immune cells can protect the brain.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Microglial Overactivation and Neuroinflammation in Animal and Human Studies
A systematic review and meta-analysis of experimental and observational studies that measure microglial activation (e.g., via biomarkers like Iba1) and neuroinflammatory outcomes (e.g., cytokine levels, cognitive function) in both animal models and human patients.
Randomized Controlled Trial of Minocycline (Microglial Inhibitor) in Patients with Neuroinflammation
A double-blind, placebo-controlled RCT where patients with neuroinflammatory conditions (e.g., multiple sclerosis) are randomly assigned to receive minocycline (or another microglial inhibitor) or placebo for a specified duration (e.g., 6 months). Outcomes include neuroinflammatory markers (e.g., CSF cytokines), MRI measures of brain tissue damage, and clinical disability scores.
Prospective Cohort Study of Autoimmune Disease Patients to Assess Microglial Overactivation and Neuroinflammation
A prospective cohort study where patients with autoimmune diseases (e.g., systemic lupus erythematosus) and healthy controls are followed over several years. Microglial activation is assessed via PET imaging or CSF biomarkers, and neuroinflammation/brain damage is measured using MRI and cognitive assessments.
Case-Control Study of Microglial Activation Markers in Patients with Neuroinflammation
A case-control study where patients diagnosed with neuroinflammation (e.g., encephalitis) are compared to age- and sex-matched healthy controls. Microglial activation is measured via CSF levels of microglial markers (e.g., soluble TREM2) and neuroinflammation is confirmed by imaging.
Animal Model Study of LPS-Induced Microglial Overactivation and Neuroinflammation in Mice
A controlled animal experiment where mice are injected with lipopolysaccharide (LPS) or other agents to overactivate microglia, and then assessed for neuroinflammation (e.g., cytokine levels, microglial morphology) and brain damage (e.g., neuronal loss, brain atrophy) over time. Include a control group without treatment.